CSL insider Kevin Zdimal plans 4,862-share sale

CSL insider Kevin Zdimal has filed a notice to sell 4,862 shares of Common Stock.

Accepted by SEC EDGAR 02/10/2026 - 05:24 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CSL insider Kevin Zdimal has filed a notice to sell 4,862 shares of Common Stock. The planned sale, through UBS Financial Services Inc., has an aggregate market value of $1,944,800 based on the filing and is listed for execution on 02/10/2026 on the NYSE.

The filing notes that 41,700,000 shares of Common Stock were outstanding. The shares to be sold were acquired on 01/31/2026 from the issuer via restricted stock awards (994 shares) and performance stock units (3,868 shares. In the past three months, Zdimal also sold 19,318 Common Stock shares for gross proceeds of $7,841,012.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for CSL disclose about Kevin Zdimal?

The filing shows that Kevin Zdimal plans to sell 4,862 CSL common shares through UBS Financial Services on 02/10/2026. It also reports a recent sale of 19,318 shares for $7,841,012 in gross proceeds.

How many CSL shares is Kevin Zdimal planning to sell under this Form 144?

The notice covers a planned sale of 4,862 CSL common shares. These shares have an indicated aggregate market value of $1,944,800 and are to be sold on the NYSE through UBS Financial Services Inc.

What prior CSL stock sales by Kevin Zdimal are reported in this Form 144?

The filing reports that Kevin Zdimal sold 19,318 shares of CSL common stock on 02/10/2026, generating $7,841,012 in gross proceeds. This disclosure covers sales in the three months preceding the new planned transaction.

How were the CSL shares in Kevin Zdimal’s planned sale acquired?

The shares were acquired from the issuer on 01/31/2026 via equity awards. Zdimal received 994 shares through a restricted stock award (RSA) and 3,868 shares through performance stock units (PSU), all recorded as Common Stock.

What is the reported market value and share count context for CSL in this filing?

The 4,862 shares covered by the planned sale have an aggregate market value of $1,944,800. The document also notes that 41,700,000 CSL common shares were outstanding, providing context for the scale of the transaction.

Which broker and exchange are involved in Kevin Zdimal’s CSL share sale?

The Form 144 lists UBS Financial Services Inc., based in Weehawken, New Jersey, as the broker handling the transaction. The NYSE is identified as the securities exchange where the CSL common shares are to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001492140
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CARLISLE COMPANIES INC
SEC File Number	001-09278
Address of Issuer	16430 N. SCOTTSDALE RD., SUITE 400 Arizona ARIZONA 85254
Phone	480-781-5000
Name of Person for Whose Account the Securities are To Be Sold	Kevin Zdimal
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	4862	1944800	41700000	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/31/2026	RSA	Issuer			994	01/31/2026	N/A
Common Stock	01/31/2026	PSU	Issuer			3868	01/31/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin Zdimal 16430 N. SCOTTSDALE RD., SUITE 400 Scottsdale AZ 85254	Common Stock	02/10/2026	19318	7841012

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Kevin Zdimal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)